Montréal-based Coral secures $4.1M in Seed funding to enhance digital health solutions for women navigating menopause, aiming to revolutionize care in Canada.
Target Information
Coral, a digital health startup based in Montréal, focuses on advancing women's health by providing innovative solutions tailored specifically for women experiencing perimenopause, menopause, and beyond. The company was founded by a skilled leadership team including Chairwoman Anna Chif, CEO Fiona Lake Waslander, and CTO John McCalla, who bring a wealth of experience and passion for improving women's healthcare.
Coral's platform delivers comprehensive digital health solutions which encompass health assessments, personalized treatment plans, and integrated team-based medical support. Their approach combines at-home testing with lifestyle guidance and prescription-based care to ensure women receive holistic and effective management of their health throughout their transitional life stages.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in Canada
The women's health sector in Canada has seen a notable shift toward digital solutions, especially in light of increasing awareness around women's unique health needs. As more women reach perimenopause and menopause, the de
Similar Deals
Sectoral Asset Management, Genesys Capital, Desjardins Capital, Seido Capital, Private Investors → Antegrade Medical Inc.
2025
Brightspark
invested in
Coral
in 2025
in a Seed Stage deal
Disclosed details
Transaction Size: $4M